nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.117	0.233	CbGbCtD
Fingolimod—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0653	0.131	CbGbCtD
Fingolimod—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0653	0.131	CbGbCtD
Fingolimod—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0582	0.116	CbGbCtD
Fingolimod—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0548	0.11	CbGbCtD
Fingolimod—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.037	0.074	CbGbCtD
Fingolimod—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0353	0.0706	CbGbCtD
Fingolimod—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0315	0.063	CbGbCtD
Fingolimod—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0185	0.0369	CbGbCtD
Fingolimod—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0174	0.0349	CbGbCtD
Fingolimod—Varicella—Montelukast—chronic obstructive pulmonary disease	0.0126	0.0673	CcSEcCtD
Fingolimod—CYP4F2—respiratory system—chronic obstructive pulmonary disease	0.0112	0.099	CbGeAlD
Fingolimod—S1PR1—respiratory system—chronic obstructive pulmonary disease	0.00877	0.0774	CbGeAlD
Fingolimod—CYP4F2—trachea—chronic obstructive pulmonary disease	0.00829	0.0731	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00801	0.0707	CbGeAlD
Fingolimod—S1PR1—connective tissue—chronic obstructive pulmonary disease	0.00772	0.0681	CbGeAlD
Fingolimod—S1PR4—lung—chronic obstructive pulmonary disease	0.00757	0.0668	CbGeAlD
Fingolimod—SPHK1—bronchus—chronic obstructive pulmonary disease	0.00714	0.063	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00706	0.0623	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00699	0.0617	CbGeAlD
Fingolimod—CYP4F12—bronchus—chronic obstructive pulmonary disease	0.00686	0.0605	CbGeAlD
Fingolimod—SPHK1—trachea—chronic obstructive pulmonary disease	0.00641	0.0566	CbGeAlD
Fingolimod—CYP4F12—trachea—chronic obstructive pulmonary disease	0.00616	0.0544	CbGeAlD
Fingolimod—S1PR3—lung—chronic obstructive pulmonary disease	0.00528	0.0466	CbGeAlD
Fingolimod—Lower respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00509	0.0272	CcSEcCtD
Fingolimod—Lower respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00509	0.0272	CcSEcCtD
Fingolimod—S1PR1—lung—chronic obstructive pulmonary disease	0.00466	0.0411	CbGeAlD
Fingolimod—SPHK1—lung—chronic obstructive pulmonary disease	0.00461	0.0407	CbGeAlD
Fingolimod—Traumatic liver injury—Montelukast—chronic obstructive pulmonary disease	0.00457	0.0245	CcSEcCtD
Fingolimod—CYP4F12—lung—chronic obstructive pulmonary disease	0.00443	0.0391	CbGeAlD
Fingolimod—Gamma-glutamyltransferase increased—Roflumilast—chronic obstructive pulmonary disease	0.00417	0.0223	CcSEcCtD
Fingolimod—Herpes zoster—Tiotropium—chronic obstructive pulmonary disease	0.00286	0.0153	CcSEcCtD
Fingolimod—Herpes zoster—Formoterol—chronic obstructive pulmonary disease	0.00231	0.0124	CcSEcCtD
Fingolimod—Herpes zoster—Arformoterol—chronic obstructive pulmonary disease	0.00231	0.0124	CcSEcCtD
Fingolimod—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00215	0.0115	CcSEcCtD
Fingolimod—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00203	0.0108	CcSEcCtD
Fingolimod—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00195	0.0104	CcSEcCtD
Fingolimod—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.0103	CcSEcCtD
Fingolimod—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.0103	CcSEcCtD
Fingolimod—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.0103	CcSEcCtD
Fingolimod—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00191	0.0102	CcSEcCtD
Fingolimod—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00962	CcSEcCtD
Fingolimod—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00959	CcSEcCtD
Fingolimod—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00959	CcSEcCtD
Fingolimod—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.00905	CcSEcCtD
Fingolimod—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.0016	0.00855	CcSEcCtD
Fingolimod—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.0083	CcSEcCtD
Fingolimod—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.00807	CcSEcCtD
Fingolimod—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.00775	CcSEcCtD
Fingolimod—Gastroenteritis—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00762	CcSEcCtD
Fingolimod—Gastroenteritis—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00762	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00141	0.253	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00141	0.253	CbGdCrCtD
Fingolimod—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.00141	0.0124	CbGeAlD
Fingolimod—Gastroenteritis—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00746	CcSEcCtD
Fingolimod—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00736	CcSEcCtD
Fingolimod—SPHK1—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.247	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.247	CbGdCrCtD
Fingolimod—Gastroenteritis—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.0072	CcSEcCtD
Fingolimod—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00716	CcSEcCtD
Fingolimod—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.0071	CcSEcCtD
Fingolimod—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00708	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00678	CcSEcCtD
Fingolimod—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.0065	CcSEcCtD
Fingolimod—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00642	CcSEcCtD
Fingolimod—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00635	CcSEcCtD
Fingolimod—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00628	CcSEcCtD
Fingolimod—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00605	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00596	CcSEcCtD
Fingolimod—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00584	CcSEcCtD
Fingolimod—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00584	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00584	CcSEcCtD
Fingolimod—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00572	CcSEcCtD
Fingolimod—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00569	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00565	CcSEcCtD
Fingolimod—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00564	CcSEcCtD
Fingolimod—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00561	CcSEcCtD
Fingolimod—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00561	CcSEcCtD
Fingolimod—Blood triglycerides increased—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00559	CcSEcCtD
Fingolimod—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00551	CcSEcCtD
Fingolimod—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00103	0.0055	CcSEcCtD
Fingolimod—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00543	CcSEcCtD
Fingolimod—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00541	CcSEcCtD
Fingolimod—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000991	0.0053	CcSEcCtD
Fingolimod—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000982	0.00525	CcSEcCtD
Fingolimod—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000976	0.00522	CcSEcCtD
Fingolimod—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000959	0.00513	CcSEcCtD
Fingolimod—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000953	0.0051	CcSEcCtD
Fingolimod—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000953	0.0051	CcSEcCtD
Fingolimod—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000948	0.00507	CcSEcCtD
Fingolimod—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000913	0.00488	CcSEcCtD
Fingolimod—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000913	0.00488	CcSEcCtD
Fingolimod—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000912	0.00488	CcSEcCtD
Fingolimod—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000894	0.00478	CcSEcCtD
Fingolimod—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000888	0.00475	CcSEcCtD
Fingolimod—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000883	0.00472	CcSEcCtD
Fingolimod—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000877	0.00469	CcSEcCtD
Fingolimod—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000862	0.00461	CcSEcCtD
Fingolimod—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000859	0.00459	CcSEcCtD
Fingolimod—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000859	0.00459	CcSEcCtD
Fingolimod—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000841	0.0045	CcSEcCtD
Fingolimod—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000837	0.00448	CcSEcCtD
Fingolimod—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000833	0.00445	CcSEcCtD
Fingolimod—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000822	0.0044	CcSEcCtD
Fingolimod—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000814	0.00435	CcSEcCtD
Fingolimod—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000811	0.00434	CcSEcCtD
Fingolimod—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000811	0.00434	CcSEcCtD
Fingolimod—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000811	0.00434	CcSEcCtD
Fingolimod—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00081	0.00433	CcSEcCtD
Fingolimod—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000809	0.00433	CcSEcCtD
Fingolimod—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.0008	0.00428	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000797	0.00426	CcSEcCtD
Fingolimod—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000794	0.00425	CcSEcCtD
Fingolimod—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000787	0.00421	CcSEcCtD
Fingolimod—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000787	0.00421	CcSEcCtD
Fingolimod—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000771	0.00413	CcSEcCtD
Fingolimod—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000766	0.0041	CcSEcCtD
Fingolimod—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000766	0.0041	CcSEcCtD
Fingolimod—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000765	0.00409	CcSEcCtD
Fingolimod—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000765	0.00409	CcSEcCtD
Fingolimod—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000764	0.00409	CcSEcCtD
Fingolimod—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000762	0.00408	CcSEcCtD
Fingolimod—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000754	0.00403	CcSEcCtD
Fingolimod—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00075	0.00401	CcSEcCtD
Fingolimod—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000748	0.004	CcSEcCtD
Fingolimod—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000747	0.004	CcSEcCtD
Fingolimod—CYP2E1—lung—chronic obstructive pulmonary disease	0.000747	0.00659	CbGeAlD
Fingolimod—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000744	0.00398	CcSEcCtD
Fingolimod—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000736	0.00393	CcSEcCtD
Fingolimod—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000736	0.00393	CcSEcCtD
Fingolimod—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000723	0.00387	CcSEcCtD
Fingolimod—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000695	0.00372	CcSEcCtD
Fingolimod—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000691	0.00369	CcSEcCtD
Fingolimod—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000672	0.00359	CcSEcCtD
Fingolimod—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000672	0.00359	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000664	0.00355	CcSEcCtD
Fingolimod—Cough—Formoterol—chronic obstructive pulmonary disease	0.000664	0.00355	CcSEcCtD
Fingolimod—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000664	0.00355	CcSEcCtD
Fingolimod—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000658	0.00352	CcSEcCtD
Fingolimod—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000657	0.00351	CcSEcCtD
Fingolimod—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.00351	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00065	0.00348	CcSEcCtD
Fingolimod—Cough—Montelukast—chronic obstructive pulmonary disease	0.00065	0.00348	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000643	0.00344	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000643	0.00344	CcSEcCtD
Fingolimod—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.00339	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00063	0.00337	CcSEcCtD
Fingolimod—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00335	CcSEcCtD
Fingolimod—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.00332	CcSEcCtD
Fingolimod—Infection—Formoterol—chronic obstructive pulmonary disease	0.000617	0.0033	CcSEcCtD
Fingolimod—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.0033	CcSEcCtD
Fingolimod—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000609	0.00326	CcSEcCtD
Fingolimod—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000609	0.00326	CcSEcCtD
Fingolimod—Infection—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00323	CcSEcCtD
Fingolimod—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000603	0.00322	CcSEcCtD
Fingolimod—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000603	0.00322	CcSEcCtD
Fingolimod—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000596	0.00319	CcSEcCtD
Fingolimod—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000591	0.00316	CcSEcCtD
Fingolimod—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00311	CcSEcCtD
Fingolimod—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00058	0.0031	CcSEcCtD
Fingolimod—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.0031	CcSEcCtD
Fingolimod—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000577	0.00309	CcSEcCtD
Fingolimod—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000575	0.00307	CcSEcCtD
Fingolimod—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00304	CcSEcCtD
Fingolimod—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000558	0.00298	CcSEcCtD
Fingolimod—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00296	CcSEcCtD
Fingolimod—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00296	CcSEcCtD
Fingolimod—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00293	CcSEcCtD
Fingolimod—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00292	CcSEcCtD
Fingolimod—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00291	CcSEcCtD
Fingolimod—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000539	0.00288	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00287	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00287	CcSEcCtD
Fingolimod—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00286	CcSEcCtD
Fingolimod—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00286	CcSEcCtD
Fingolimod—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00281	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000525	0.00281	CcSEcCtD
Fingolimod—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000524	0.0028	CcSEcCtD
Fingolimod—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.00279	CcSEcCtD
Fingolimod—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000511	0.00273	CcSEcCtD
Fingolimod—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000509	0.00272	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00271	CcSEcCtD
Fingolimod—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.0027	CcSEcCtD
Fingolimod—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000482	0.00258	CcSEcCtD
Fingolimod—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000482	0.00258	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000473	0.00253	CcSEcCtD
Fingolimod—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00238	CcSEcCtD
Fingolimod—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00238	CcSEcCtD
Fingolimod—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00235	CcSEcCtD
Fingolimod—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00235	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00234	CcSEcCtD
Fingolimod—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00233	CcSEcCtD
Fingolimod—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00043	0.0023	CcSEcCtD
Fingolimod—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00227	CcSEcCtD
Fingolimod—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00227	CcSEcCtD
Fingolimod—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00225	CcSEcCtD
Fingolimod—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000416	0.00222	CcSEcCtD
Fingolimod—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00222	CcSEcCtD
Fingolimod—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00041	0.0022	CcSEcCtD
Fingolimod—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.0022	CcSEcCtD
Fingolimod—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00215	CcSEcCtD
Fingolimod—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00214	CcSEcCtD
Fingolimod—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00208	CcSEcCtD
Fingolimod—Headache—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00208	CcSEcCtD
Fingolimod—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000389	0.00208	CcSEcCtD
Fingolimod—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.00208	CcSEcCtD
Fingolimod—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00207	CcSEcCtD
Fingolimod—Depression—Prednisone—chronic obstructive pulmonary disease	0.000382	0.00204	CcSEcCtD
Fingolimod—Headache—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00204	CcSEcCtD
Fingolimod—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00196	CcSEcCtD
Fingolimod—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000356	0.0019	CcSEcCtD
Fingolimod—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00187	CcSEcCtD
Fingolimod—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000338	0.00181	CcSEcCtD
Fingolimod—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000321	0.00172	CcSEcCtD
Fingolimod—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00167	CcSEcCtD
Fingolimod—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00163	CcSEcCtD
Fingolimod—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.00161	CcSEcCtD
Fingolimod—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00161	CcSEcCtD
Fingolimod—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00151	CcSEcCtD
Fingolimod—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00138	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00135	CcSEcCtD
Fingolimod—Infection—Prednisone—chronic obstructive pulmonary disease	0.000243	0.0013	CcSEcCtD
Fingolimod—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00128	CcSEcCtD
Fingolimod—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00127	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000237	0.00122	CbGpPWpGaD
Fingolimod—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00122	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000235	0.00121	CbGpPWpGaD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.0012	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000231	0.00119	CbGpPWpGaD
Fingolimod—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000231	0.00119	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000226	0.00116	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000226	0.00116	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000226	0.00116	CbGpPWpGaD
Fingolimod—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.00119	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000222	0.00114	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000222	0.00114	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000221	0.00114	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000221	0.00114	CbGpPWpGaD
Fingolimod—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00117	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000216	0.00111	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000213	0.00109	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000213	0.00109	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000212	0.00109	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000212	0.00109	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000212	0.00109	CbGpPWpGaD
Fingolimod—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00113	CcSEcCtD
Fingolimod—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00113	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00021	0.00108	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000207	0.00107	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000205	0.00106	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000204	0.00105	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000202	0.00104	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000202	0.00104	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000202	0.00104	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000202	0.00104	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.00103	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000194	0.001	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000194	0.001	CbGpPWpGaD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.000999	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000193	0.000994	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000193	0.000994	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000191	0.000982	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000189	0.000976	CbGpPWpGaD
Fingolimod—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000189	0.000973	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000187	0.000962	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000187	0.000961	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000183	0.000944	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000183	0.000944	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000181	0.000931	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000178	0.000915	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000176	0.000909	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000176	0.000909	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000176	0.000909	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000176	0.000905	CbGpPWpGaD
Fingolimod—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000937	CcSEcCtD
Fingolimod—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000924	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.000886	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000171	0.00088	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000171	0.000879	CbGpPWpGaD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.000874	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000169	0.000869	CbGpPWpGaD
Fingolimod—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000168	0.000863	CbGpPWpGaD
Fingolimod—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000894	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000166	0.000856	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000164	0.000844	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000164	0.000844	CbGpPWpGaD
Fingolimod—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000864	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000161	0.000832	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00016	0.000826	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00016	0.000825	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000156	0.000805	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000155	0.000801	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000155	0.000801	CbGpPWpGaD
Fingolimod—Headache—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000819	CcSEcCtD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.000787	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000153	0.000786	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.000777	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00015	0.000773	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.000761	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.000745	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000144	0.000744	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000144	0.000744	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000143	0.000739	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00073	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000141	0.000728	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000141	0.000727	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00072	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000139	0.000714	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.000709	CbGpPWpGaD
Fingolimod—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.000707	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000133	0.000687	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000133	0.000687	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000132	0.000679	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000131	0.000676	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.000643	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000125	0.000643	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000125	0.000642	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.000638	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000124	0.000638	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000123	0.000635	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000121	0.000626	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000121	0.000624	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000121	0.000624	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.00012	0.000619	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00012	0.000618	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00012	0.000618	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00012	0.000616	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000119	0.000614	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000119	0.000614	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000118	0.000609	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000117	0.000601	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000116	0.000598	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000113	0.000583	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000113	0.000583	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000113	0.00058	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.000572	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.000564	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000109	0.000562	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000109	0.000562	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000109	0.000562	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000109	0.00056	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000108	0.000558	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000108	0.000558	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000108	0.000558	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000108	0.000557	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.000553	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000107	0.000552	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000107	0.000552	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000104	0.000537	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000104	0.000537	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.000531	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.000523	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000101	0.000519	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.000518	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.92e-05	0.000511	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.9e-05	0.00051	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ALB—chronic obstructive pulmonary disease	9.84e-05	0.000507	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.84e-05	0.000507	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.69e-05	0.000499	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.69e-05	0.000499	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.58e-05	0.000493	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.47e-05	0.000488	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—NOS3—chronic obstructive pulmonary disease	9.41e-05	0.000485	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9e-05	0.000463	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.8e-05	0.000453	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.7e-05	0.000448	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ALB—chronic obstructive pulmonary disease	8.49e-05	0.000437	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.39e-05	0.000432	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.38e-05	0.000432	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	8.29e-05	0.000427	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.28e-05	0.000426	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.28e-05	0.000426	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.12e-05	0.000418	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.97e-05	0.00041	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.97e-05	0.00041	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.92e-05	0.000408	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.9e-05	0.000407	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.82e-05	0.000403	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.79e-05	0.000401	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.71e-05	0.000397	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.61e-05	0.000392	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.61e-05	0.000392	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.61e-05	0.000392	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.54e-05	0.000389	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.31e-05	0.000377	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ALB—chronic obstructive pulmonary disease	7.3e-05	0.000376	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.26e-05	0.000374	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.26e-05	0.000374	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.24e-05	0.000373	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.21e-05	0.000371	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.98e-05	0.000359	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.91e-05	0.000356	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.69e-05	0.000345	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.59e-05	0.00034	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.58e-05	0.000339	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.49e-05	0.000334	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.44e-05	0.000332	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.44e-05	0.000332	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.36e-05	0.000328	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.12e-05	0.000315	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.12e-05	0.000315	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.11e-05	0.000315	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.05e-05	0.000312	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.88e-05	0.000303	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.85e-05	0.000301	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.84e-05	0.000301	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.83e-05	0.0003	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.83e-05	0.0003	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.56e-05	0.000286	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.49e-05	0.000283	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.49e-05	0.000283	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.43e-05	0.00028	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.41e-05	0.000279	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	5.34e-05	0.000275	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.29e-05	0.000272	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.23e-05	0.000269	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.23e-05	0.000269	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.18e-05	0.000267	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.04e-05	0.00026	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.99e-05	0.000257	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.97e-05	0.000256	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.97e-05	0.000256	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.89e-05	0.000252	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.8e-05	0.000247	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.8e-05	0.000247	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.78e-05	0.000246	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.75e-05	0.000245	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.71e-05	0.000243	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.71e-05	0.000242	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.71e-05	0.000242	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.68e-05	0.000241	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.36e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.27e-05	0.00022	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.2e-05	0.000217	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.11e-05	0.000211	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.95e-05	0.000204	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.95e-05	0.000204	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.9e-05	0.000201	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.86e-05	0.000199	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.85e-05	0.000198	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.79e-05	0.000195	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.78e-05	0.000195	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.76e-05	0.000194	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.62e-05	0.000186	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.62e-05	0.000186	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.59e-05	0.000185	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.52e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.29e-05	0.000169	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.18e-05	0.000164	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.92e-05	0.00015	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.91e-05	0.00015	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.88e-05	0.000149	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.63e-05	0.000136	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.55e-05	0.000131	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.48e-05	0.000128	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.42e-05	0.000125	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.3e-05	0.000119	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.07e-05	0.000107	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.05e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.02e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.99e-05	0.000103	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-05	9.62e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.86e-05	9.57e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	9.08e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	8.86e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.44e-05	7.39e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.42e-05	7.29e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	6.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.34e-05	6.89e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	6.79e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	6.44e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	6.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.2e-05	6.17e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.15e-05	5.9e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	5.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.38e-06	4.83e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.25e-06	4.77e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.62e-06	4.44e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.5e-06	4.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.17e-06	4.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.13e-06	4.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.56e-06	2.86e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.31e-06	2.74e-05	CbGpPWpGaD
